M
Milo Zachmann
Researcher at University of Zurich
Publications - 119
Citations - 4132
Milo Zachmann is an academic researcher from University of Zurich. The author has contributed to research in topics: Congenital adrenal hyperplasia & Bone age. The author has an hindex of 37, co-authored 119 publications receiving 4041 citations. Previous affiliations of Milo Zachmann include University of St. Gallen.
Papers
More filters
Journal ArticleDOI
Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients.
TL;DR: It is concluded that the clinical and biochemical expression of 11 beta-hydroxylase deficiency is variable, that hypertension in not directly related to deoxycorticosterone, and that, regardless of the intensity of the defect, there are patients in whom the 11 Beta-Hydroxylation of 17 alpha-hydroxyylated steroids only is impaired.
Journal ArticleDOI
Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.
Eric Rhéaume,Jacques Simard,Yves Morel,Farida Mebarki,Milo Zachmann,Maguelone G. Forest,Maria I. New,Fernand Labrie +7 more
TL;DR: The nucleotide sequence of the two highly homologous genes encoding 3β–HSD isoenzymes in three classic 3β-HSD deficient patients belonging to two apparently unrelated pedigrees is described, providing the first elucidation of the molecular basis of this disorder.
Journal ArticleDOI
Genetic Mapping of the 21-Hydroxylase-Deficiency Gene within the HLA Linkage Group
Lenore S. Levine,Milo Zachmann,Maria I. New,Andrea Prader,Marilyn S. Pollack,O'Neill Gj,Soo Young Yang,Sharon E. Oberfield,Bo Dupont +8 more
TL;DR: Close genetic linkage between HLA-B and 21-hydroxylase deficiency was established and a link between congenital adrenal hyperplasia and HLA was established.
Journal ArticleDOI
Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various patholgoic conditions†
TL;DR: It is concluded that calculations based on coefficients and regression equations obtained from normal children (as in the Roche-Wainer-Thissen and Tanner methods) can only be used in normal children or in patients with normal growth potential under adequate treatment.
Journal ArticleDOI
Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism
TL;DR: It is concluded that testosterone exerts its full growth-promoting action only in the presence of normal endogenous GH secretion or with sufficient hGH replacement and that both hormones should be continued simultaneously until final adult height is achieved.